Home / Inspections / 1187380

FDA Inspection 1187380 — Piedmont Reproductive Endocrinology Group, PA

Piedmont Reproductive Endocrinology Group, PA — FEI 3013611101

The FDA completed an inspection of Piedmont Reproductive Endocrinology Group, PA on November 1, 2022 in West Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 1, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
West Columbia, SC (United States)

Facility

Other inspections at this facility

  • 1091218 (NAI Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1016583 (NAI Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources